Discover James Corden’s journey with Tudor disease a rare condition linked to gout Learn its symptoms causes and treatments ...

Dr Hilary Jones, resident GP at ITV's Good Morning Britain, said he had discoloured nails, joint pain that would worsen at ...

Dr Hilary Jones has said that the prevalence of gout is set to increase up to 70 per cent in the coming years - and ...

The following is a summary of “Knowledge of and Stated Adherence to the 2020 American College of Rheumatology Guideline for ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When ...

XORTX Therapeutics Inc ( ($TSE:XRTX) ) has issued an update. XORTX Therapeutics Inc. announced a change of auditor, appointing Davidson & Company ...

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), ...

Gout flares among adults in the United States are significantly underreported to healthcare providers, with nearly 72% of flares either not reported or pretreated/prevented by patients, according to ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding NDA filing CALGARY, Alberta, Jan. 06, 2025 (GLOBE NEWSWIRE) -- XORTX ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

(MENAFN- GlobeNewsWire - Nasdaq) XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding NDA filing With the clinical ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding NDA filing CALGARY, Alberta, Jan. 06, 2025 (GLOBE NEWSWIRE ...